vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $27.6M, roughly 1.7× Maison Solutions Inc.). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -18.0%, a 13.2% gap on every dollar of revenue. On growth, Maison Solutions Inc. posted the faster year-over-year revenue change (-10.9% vs -47.3%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
IRWD vs MSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $27.6M |
| Net Profit | $-2.3M | $-5.0M |
| Gross Margin | — | 23.4% |
| Operating Margin | 14.3% | -4.9% |
| Net Margin | -4.8% | -18.0% |
| Revenue YoY | -47.3% | -10.9% |
| Net Profit YoY | -200.9% | -1840.5% |
| EPS (diluted) | $0.01 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $27.6M | ||
| Q3 25 | $122.1M | $27.2M | ||
| Q2 25 | $85.2M | $34.4M | ||
| Q1 25 | $41.1M | $32.3M | ||
| Q4 24 | $90.5M | $29.4M | ||
| Q3 24 | $91.6M | $28.2M | ||
| Q2 24 | $94.4M | $16.9M | ||
| Q1 24 | $74.9M | $13.6M |
| Q4 25 | $-2.3M | $-5.0M | ||
| Q3 25 | $40.1M | $-1.5M | ||
| Q2 25 | $23.6M | $-287.4K | ||
| Q1 25 | $-37.4M | $1.0M | ||
| Q4 24 | $2.3M | $-256.0K | ||
| Q3 24 | $3.6M | $700.9K | ||
| Q2 24 | $-860.0K | $-2.8M | ||
| Q1 24 | $-4.2M | $-549.0K |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 21.8% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 23.4% |
| Q4 25 | 14.3% | -4.9% | ||
| Q3 25 | 61.8% | 0.7% | ||
| Q2 25 | 53.2% | -15.9% | ||
| Q1 25 | -70.7% | 3.7% | ||
| Q4 24 | 34.8% | 3.2% | ||
| Q3 24 | 28.0% | 7.3% | ||
| Q2 24 | 26.5% | -14.4% | ||
| Q1 24 | 14.7% | -2.3% |
| Q4 25 | -4.8% | -18.0% | ||
| Q3 25 | 32.8% | -5.7% | ||
| Q2 25 | 27.7% | -0.8% | ||
| Q1 25 | -90.9% | 3.1% | ||
| Q4 24 | 2.5% | -0.9% | ||
| Q3 24 | 4.0% | 2.5% | ||
| Q2 24 | -0.9% | -16.4% | ||
| Q1 24 | -5.6% | -4.0% |
| Q4 25 | $0.01 | $-0.23 | ||
| Q3 25 | $0.23 | $-0.08 | ||
| Q2 25 | $0.14 | $-0.02 | ||
| Q1 25 | $-0.23 | $0.06 | ||
| Q4 24 | $0.03 | $-0.01 | ||
| Q3 24 | $0.02 | $0.04 | ||
| Q2 24 | $-0.01 | $-0.16 | ||
| Q1 24 | $-0.03 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $-261.8M | $11.6M |
| Total Assets | $396.9M | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | $1.1M | ||
| Q2 25 | $92.9M | $775.4K | ||
| Q1 25 | $108.5M | $445.4K | ||
| Q4 24 | $88.6M | $355.7K | ||
| Q3 24 | $88.2M | $588.9K | ||
| Q2 24 | $105.5M | $2.1M | ||
| Q1 24 | $121.5M | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | $199.5M | $2.6M | ||
| Q2 25 | $199.3M | $2.6M | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | $2.5M | ||
| Q2 24 | $198.6M | $2.6M | ||
| Q1 24 | $398.3M | $2.6M |
| Q4 25 | $-261.8M | $11.6M | ||
| Q3 25 | $-264.2M | $10.1M | ||
| Q2 25 | $-308.2M | $11.7M | ||
| Q1 25 | $-334.1M | $12.0M | ||
| Q4 24 | $-301.3M | $10.9M | ||
| Q3 24 | $-311.3M | $11.2M | ||
| Q2 24 | $-321.7M | $10.5M | ||
| Q1 24 | $-330.5M | $13.3M |
| Q4 25 | $396.9M | $75.4M | ||
| Q3 25 | $396.1M | $73.3M | ||
| Q2 25 | $342.9M | $77.4M | ||
| Q1 25 | $327.2M | $82.7M | ||
| Q4 24 | $350.9M | $82.7M | ||
| Q3 24 | $389.5M | $82.1M | ||
| Q2 24 | $395.6M | $82.4M | ||
| Q1 24 | $438.8M | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-1.7M |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $-1.7M | ||
| Q3 25 | $47.6M | $1.1M | ||
| Q2 25 | $-15.1M | $-1.6M | ||
| Q1 25 | $20.0M | $1.7M | ||
| Q4 24 | $15.2M | $1.1M | ||
| Q3 24 | $9.9M | $3.6M | ||
| Q2 24 | $33.5M | $-2.6M | ||
| Q1 24 | $45.0M | $-1.4M |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
